Risk calculator developed by UCLA and Los Angeles LGBT Center may fill that void A new study from the UCLA Fielding School of Public Health suggests modifying federal health guidelines related to the use of pre-exposure prophylaxis to prevent HIV transmission because current standards could miss ...

TreatmentUpdate is CATIE’s flagship digest on cutting-edge developments in HIV and hepatitis C research and treatment. TreatmentUpdate 218: Research with women and HIV, December 2016 issue is available at: http://www.catie.ca/en/treatmentupdate/treatmentupdate-218 Original Article

Vemlidy® is the first new treatment for chronic hepatitis B infection to be approved in the European Union in nearly a decade Gilead Sciences, Inc. (Nasdaq: GILD) announced that the European Commission has granted marketing authorization for Vemlidy® (tenofovir alafenamide, TAF) 25 mg, a once-daily tablet ...

CytoDyn Inc. (OTC.QB:CYDY), a biotechnology company focused on the development of new therapies for combating human immunodeficiency virus (HIV) infection, today announced the Company filed a request for Breakthrough Therapy Designation with the FDA for PRO 140 as a treatment for HIV-1 infection in treatment-experienced ...

Patients with hepatitis C virus infection who received an antiviral drug around the time they underwent liver transplantation saw a high rate of sustained virologic response, according to a Northwestern Medicine phase II clinical trial. The finding suggests that the therapy might be an effective ...

The mini pump could be key to eradicating a scourge in Africa. You don't have to wait until after an infection to fight HIV. A technique known as pre-exposure prophylaxis has you taking preemptive medicine on a regular basis, greatly reducing the chances that HIV will ...

European doctors ask the question at 2016 Standard of Care meeting The purpose and structure of clinical HIV guidelines may have to change radically now that universal treatment on diagnosis is the clinical consensus, physicians from the European AIDS Clinical Society (EACS) heard in a meeting ...

UCLA-led researchers suggest that blocking type I interferon may help combat the virus that causes AIDS In findings they call counterintuitive, a team of UCLA-led researchers suggests that blocking a protein, which is crucial to initiating the immune response against viral infections, may actually help combat ...

During the early (also known as acute) stage of HIV infection—about two weeks after initial exposure—the amount of virus produced in the body is very high. This occurs because the virus has overwhelmed and subverted the body’s defences. As acute infection is not associated with ...

ABIVAX reports new preclinical data supporting ABX464 as HIV functional cure and novel treatment for inflammatory diseases at HIV DART Meeting ABIVAX provides update on clinical development program for ABX464 for functional cure of patients with HIV-infection Original Article

With hepatitis C (HCV) being curable with direct-acting antivirals in eight to 12 weeks or less, the question arises whether we can transplant HCV-positive organs to HCV-negative patients safely with treatment. In a large study of U.S. kidney transplant recipients, five-year graft and patient survival ...

Actor Charlie Sheen revealed this month that he has achieved an undetectable viral load by taking PRO 140, an injectable HIV drug that’s currently being studied, according to a report in the Daily Mail. “It’s impossibly amazing. Personally, I think about how I felt on the ...

A CALL TO ACTION BY THE BEYOND VIRAL SUPPRESSION INITIATIVE Improving Outcomes for People Living with HIV This is a call to action for European governments, international organisations, patient organisations, and the wider health community to align on a new HIV policy agenda that addresses the crucial ...

People who inject drugs (PWID) can have an excellent response to sofosbuvir-based therapy for hepatitis C virus (HCV) infection, Ukrainian research presented to the recent 2016 AASLD Liver Meeting shows. Overall, 93% of people had a sustained virological response 12 weeks (SVR12) after the completion of ...

Scientists are taking the battle to prevent HIV to the next level with large-scale trials set to start using injections to protect vulnerable groups such as gay men and women in Africa for at least two months. Further down the road, the hope is to produce ...

“Over the past 10 years, the number of officially recorded patients who receive HIV treatment in Russia has increased five fold from 7.5 % to 37% in 2015. This figure is expected to rise …to 41.5% this year, according to preliminary reports for 2016,” Skvortsova ...

A new WHO report provides insight into how countries in the WHO European Region can improve access and reduce medicine prices through strategic and well-planned procurement processes. It also addresses collaboration within and across countries to improve availability of affordable medicines for patients in the ...

Mylan signs sub-license agreement with the Medicines Patent Pool to increase access to hepatitis C treatment in developing countries HERTFORDSHIRE, England and BENGALURU, India, Nov. 28, 2016 — Mylan N.V. (NASDAQ, TASE: MYL) today announced that the company has signed an agreement with the Medicines Patent ...